Track Group, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Derek Cassell
- Full Time Employees
- 91
- Sector
- Technology
- Industry
- Hardware, Equipment & Parts
- Address
- 5th Avenue Station Naperville IL United States of America 60563
- IPO Date
- Dec 15, 2005
- CIK
- 0001045942
- Website
- trackgrp.com
- Similar Companies
- Business
- Track Group, Inc. (TRCK) designs, manufactures, and markets electronic monitoring and location tracking devices for offender management in the criminal justice sector; its core products include ReliAlert XC4 and ReliAlert XC3 one-piece GPS devices with patented two/three-way voice communication, SHADOW RF/GPS hybrid trackers, InTouch smartphone monitoring applications, Empower victim notification systems, BACtrack Mobile alcohol monitoring breathalyzers, and a hardware-agnostic platform offering predictive analytics, software applications, professional monitoring services, accessories, and networking solutions. The company serves government agencies at federal, state, and local levels in the United States, Latin America including Puerto Rico and the Bahamas, Canada, and internationally through subsidiaries in regions such as Israel and formerly Chile. Founded in 1995 and headquartered in Naperville, Illinois, Track Group focuses on security, law enforcement, corrections, and rehabilitation markets with end-to-end solutions integrating real-time tracking, data analytics, and intervention technologies to reduce risk and support re-socialization. Recent developments include the sale of its Chilean subsidiary contributing to revenue adjustments in fiscal 2025 alongside expansions in Illinois, Puerto Rico, and the Bahamas; improved profitability with Adjusted EBITDA rising to $1.8 million in Q3 FY25 from strategic technology investments and operational streamlining; and FY25 revenue guidance of $34.5 million to $35.5 million reflecting ongoing platform enhancements despite reduced assignments in Virginia and Michigan.
Company News
Lavras Gold Approves Fourth Diamond Drill Rig to Fast-Track Cerrito North Drill Testing; Fazenda-Butia LP Application Remains on Track
SpaceX Revenue Projections Look Wildly Optimistic Based on Elon Musk's Forecasting Track Record
SOAR AI's Ohio AI Compute Campus on Track for December 31 In-Service Date, with Contracted Revenue Expected to Begin January 2027
Dario Amodei Predicted at Davos in January 2025 That AI Could Surpass Humans "at Almost Everything" Within Two to Three Years. With Anthropic Now Filing for a $2 Trillion IPO, Is That Timeline Still on Track?
The Chefs' Warehouse: A Strong Track Record Of EPS Beats
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
i-80 Gold Provides a Development Update; Archimedes Underground and Lone Tree Plant Refurbishment Remain on Track and Mineral Point Open Pit Prioritized in Updated Development Plan
XTI Aerospace Announces Completion of Internal Review; On Track to File Quarterly Report on Form 10-Q By October 26, 2026
Perspective Therapeutics Granted Fast Track Designation for [212Pb]PSV359 for the Treatment of Adult Patients with Locally Advanced Unresectable and/or Metastatic FAP-Positive Solitary Fibrous Tumors
SecureAlert (OTCMKTS:TRCK) Stock Price Breaks Below 50 Day Moving Average – Time to Sell?
Kodiak AI On Track for Year-End Driverless Long-Haul Launch as Autonomy Readiness Measure Jumps to 96%
Turning Savings into Security: Canadians Feel on Track for Retirement, But Worry About What Comes Next
Q3 Earnings on Track for 8th Consecutive Quarter of Double-Digit Growth
Are Space ETFs on Track to Rally or Is It Just a Temporary Blip?
Flexport Launches Technology to Let AI Agents Book, Track, and Optimize Global Freight
UniQure Insists Huntington's Drug Is Still on Track as Stock Plunges 48%
Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy
Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout
CEO.CA's Inside the Boardroom: Sixty North Gold on Fast-Track to Gold Mine Restart
GE Vernova: AI Public Backlash Grows, But Data Center Growth Is On Track